— Know what they know.
Not Investment Advice

OPTN NASDAQ

OptiNose, Inc.
1W: +1.9% 1M: +4.7% 3M: +60.0% 1Y: -49.2% 3Y: -65.4% 5Y: -83.6%
$9.60
Last traded 2025-05-21 — delisted
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · $97.2M mcap · 6M float · 1.87% daily turnover · Short 18% of daily vol

Balance Sheet Trends

Total Assets
$129M +19.5% ▲
5Y CAGR: -5.7%
Total Liabilities
$169M -13.0% ▼
5Y CAGR: +8.8%
Shareholders Equity
-$40M +53.4% ▲
Cash & Investments
$84M +14.7% ▲
5Y CAGR: -10.5%
Total Debt
$129M -2.1% ▼
5Y CAGR: +11.6%
Net Debt
$44M -23.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$144M$111M$94M$74M$84M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$144M$111M$94M$74M$84M
Net Receivables$23M$35M$34M$20M$26M
Inventory$9M$12M$9M$8M$11M
Other Current Assets$0$0$3M$0$4M
Total Current Assets$181M$160M$140M$105M$126M
Property, Plant & Equip.$2M$1M$795K$2M$605K
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$43M$4M$3M$109K$2M
Total Non-Current Assets$45M$6M$4M$2M$3M
Total Assets$189M$166M$144M$108M$129M
— Liabilities —
Accounts Payable$5M$8M$5M$4M$450K
Short-Term Debt$0$0$129M$130M$126M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$42M$35M$35M$29M
Total Current Liabilities$52M$59M$179M$177M$163M
Long-Term Debt$125M$126M$0$0$0
Other Non-Current Liab.$490K$0$21M$17M$5M
Total Non-Current Liabilities$130M$129M$22M$18M$6M
Total Liabilities$182M$188M$201M$194M$169M
— Equity —
Common Stock$53K$82K$111K$112K$10K
Retained Earnings-$528M-$610M-$685M-$720M-$742M
Accumulated OCI-$85K-$81K-$84K-$84K-$84K
Total Stockholders Equity$7M-$22M-$57M-$87M-$40M
Total Liabilities & Equity$189M$166M$144M$108M$129M
— Key Metrics —
Total Debt$131M$131M$131M$132M$129M
Net Debt-$19M$20M$37M$58M$44M
Total Investments$0$0$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms